ferrous-citrate and Graft-vs-Host-Disease

ferrous-citrate has been researched along with Graft-vs-Host-Disease* in 2 studies

Other Studies

2 other study(ies) available for ferrous-citrate and Graft-vs-Host-Disease

ArticleYear
5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
    Drug discoveries & therapeutics, 2021, Jan-23, Volume: 14, Issue:6

    Topics: Alanine Transaminase; Aminolevulinic Acid; Animals; Aspartate Aminotransferases; Citric Acid; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Ferrous Compounds; Gene Expression Regulation; Graft vs Host Disease; Levulinic Acids; Liver; Male; Mice; Mice, Inbred C57BL; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Sodium Citrate; T-Lymphocytes; Treatment Outcome; Up-Regulation

2021
5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model.
    International immunopharmacology, 2021, Volume: 96

    Topics: Aminolevulinic Acid; Animals; B-Lymphocytes; Blood Urea Nitrogen; Body Weight; CD8-Positive T-Lymphocytes; Citric Acid; Creatine; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrous Compounds; Fibrosis; Graft vs Host Disease; Heme Oxygenase-1; Levulinic Acids; Lupus Nephritis; Lymphocyte Activation; Membrane Proteins; Mice; Spleen; T-Lymphocytes, Regulatory

2021